The Latest “Beehind the Buzz” Show: Featuring AREV Nutrition (CSE: AREV) Chairman Mike Withrow

Published on: 19 Dec, 2018’s latest Beehind the Buzz: Chairman and Director of AREV Nutrition Sciences Inc., Mike Withrow

MJBizDaily’s flagship event, MJBizCon, is the preeminent conference to drive business deals and forge valuable connections with cannabis professionals in business today.

Mr. Withrow is a successful natural products and technology entrepreneur with over 25 years in public markets. His international trade and regulatory experience has been essential to the companies he has structured.

AREV Nutrition Sciences Inc. (CSE: AREV), produces and delivers functional ingredients from its world-class extraction system. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain management, Insomnia, Central Nervous System Disorders & Sexuality.

For more Beehind the Buzz please visit:

About Beehind the Buzz: One of’s latest corporate and financial news shows, covering the latest trending stock market news. Beehind the Buzz looks to become a leader in corporate video news dissemination. Beehind the Buzz is 100% original content, brought to you by Financial Buzz Media.


  • 3186Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Carlos Braadt



Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

22 Jun, 2017 2827
26 Jul, 2017 2812
18 Aug, 2017 2709
03 Oct, 2017 2798


There is no comment on this article